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Objectives: : Diabetes mellitus increases the risk of coronary heart disease and myocardial infarction (MI). Silent MI occurs with 
greater frequency in patients with diabetes with or without autonomic neuropathy and carries a similar prognosis to overt MI. 
Regular electrocardiographic (ECG) assessment is integral in the chronic management of patients with diabetes. Limited data 
exist on the spectrum of ECG abnormalities of black South African patients with diabetes. The primary aim of this study was a 
description of ECG abnormalities found and the secondary aim was the determination of factors associated with left ventricular 
hypertrophy (LVH) and MI.j
Setting and participants:  The study was carried out at a regional hospital diabetes clinic in Pietermaritzburg, KwaZulu-Natal. The 
initial ECGs performed on patients from October 1, 2012 to September 30, 2014 were analysed. The first ECGs of 637 black South 
African patients with diabetes were studied, representing 80.1% of all eligible patients.
Results:  The major ECG abnormalities detected were those suggestive of LVH (36.0%), MI (21.7%), conduction defects (17.7%), 
T-wave inversion (14.1%) and ventricular ectopics (6.8%). Most infarctions were silent (89.8%), and affected the inferior territory 
significantly more than anterior, lateral and antero-lateral territories (52.9% vs. 33.3% vs. 9.4% vs. 1. 5%, respectively). A substantial 
percentage of patients with MI failed to achieve target HbA1c and triglyceride levels and waist-to-height-ratios. Diet, exercise 
and self-monitoring of glucose were all associated with positive effects on both MI and LVH. A greater percentage of patients 
with LVH had evidence of MI versus those without hypertrophy (28.4% vs. 19.4%).
Conclusion:  This study demonstrates a high prevalence of undiagnosed MI within this cohort of South African patients with 
diabetes. Patients with LVH were more prone to infarction. Poor glycaemic and triglyceride control and obesity were associated 
with infarction. Improving glycaemic and lipid control together with lifestyle modification may help prevent macrovascular 
cardiac complications.
Keywords: Diabetes mellitus, coronary artery disease, left ventricular hypertrophy, macro-vascular complications,  South Africa, 
silent myocardial infarction
Introduction
Diabetes mellitus (DM) is a chronic disease with life-threatening 
micro- and macro-vascular complications. Coronary heart 
disease (CHD) is one such macro-vascular complication.1 DM is 
recognised as an independent risk factor for CHD.2 Poor 
glycaemic control escalates the risk of microvascular and possibly 
macro-vascular complications.1 Silent coronary artery disease 
described in African patients,3 and the incidence of CHD in Black 
African patients with diabetes, have been reported as lower than 
that in other populations.4 We have previously noted that the 
majority of African patients followed at the Edendale hospital 
(EDH) diabetes clinic had suboptimal glycaemic control, with a 
prevalence of CHD of 6.3%, while 2.5% of these patients reported 
a history of myocardial infarction (MI).5 Since poorly controlled 
patients with diabetes may suffer painless MI secondary to 
neuropathy, we believe these figures represent an underestimate, 
since silent myocardial ischaemia occurs more frequently in 
patients with diabetes with coronary disease and may occur with 
or without autonomic neuropathy.6 Unrecognised or silent MI 
carries a serious prognosis, which is similar to the prognosis 
carried by overt MI.7,8 In this study, we first describe the 
electrocardiographic abnormalities found among African South 
African patients with diabetes attending our regional hospital 
clinic in KwaZulu-Natal. We then proceed to identify factors 
associated with left ventricular hypertrophy and myocardial 
infarction.
Patients and methods
EDH is regional hospital situated in Pietermaritzburg, KwaZulu-
Natal. All patients seen at this clinic are advised to have a standard 
12-lead resting ECG performed annually using an Edan SE 1200® 
machine (Edan instruments Inc, China). Although all patients 
were advised to have their ECG performed, a compliance rate of 
80.1% of eligible patients was obtained. We analysed the ECG 
retrospectively for the period October 1, 2012 to September 30, 
2014. One observer interpreted ECGs and no automated ECG-
generated reports were used for analysis purposes. These ECGs 
were collected and stored on a weekly basis. The quality of the 
ECGs was good. For the purposes of this study only the first ECG 
was considered. Future studies will concentrate on changes 
noted in subsequent ECGs performed on patients. The following 
abnormalities were documented: left ventricular hypertrophy 
(LVH), right ventricular hypertrophy (RVH), bundle branch block 
(BBB), P-wave abnormalities, T-wave abnormalities, axis, presence 
of pathological Q-waves, premature ventricular complexes 
(PVCs) and arrhythmias.
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We diagnosed LVH where either of the following criteria were 
satisfied: the Sokolov-Lyon criteria (sum of amplitude of S wave in 
lead V1 or V2 and the R wave in lead V5 or V6 the amplitude of the 
R wave in lead aVL 11),9 or the Cornell voltage criteria (sum of the 
amplitude of S wave in lead V3 and R wave in lead aVL > 24 mm in 
females and 28  mm in males).10 The presence of pathologic 
Q-waves on ECG was used to diagnose prior MI. Pathologic 
Q-waves were defined as any Q-wave in leads V2–V3 ≥ 0.02s or QS 
complex in leads V2 and V3, or a Q-wave ≥ 0.03s and > 0.1 mV 
deep or QS complex in leads I, II, aVL, aVF, or V4–V6 in any two 
contiguous leads in (I, aVL, V6, V4–V6, II, II, II, III, and aVF).11 Antman 
et al. stated that an ECG with Q-waves meeting the 
abovementioned criteria is indicative of a previous MI.12 Use of 
Q-waves to diagnose prior MI was also reinforced in other studies 
conducted by Pahlm et al.,13 Horan et al.,14 Savage et al.15 and in the 
2007 universal definition of myocardial infarction consensus 
statement.11 However, using Q-waves has generally not been 
used as the conventional criterion to diagnose previous MI in 
epidemiologic studies. The territory of the infarct was classified as 
the presence of pathological Q-waves in ≥ two contiguous leads 
as follows: inferior territory: leads II, III, aVF; anterior territory: leads 
V1–V3; lateral territory: leads V5, V6, I, aVL; anterolateral territory: 
leads V1–V6 in addition to I, aVL. We recorded T-wave inversion 
when there was inversion of the T-wave in two or more adjacent 
leads in the absence of features of LVH. If LVH was present, then 
T-wave inversion was classified as LVH with strain pattern.
Left axis deviation (LAD) was diagnosed based on a hexaxial 
reference system when the R axis was between –30⁰ and –90⁰ and 
right axis deviation (RAD) diagnosed when the R axis was 
between + 90⁰ and + 180⁰. Left anterior fascicular block (LAFB) was 
diagnosed when there was LAD and T-wave inversion in lead aVL. 
Bifasicular block was documented when there was left anterior 
hemiblock present together with right bundle branch block (RBBB). 
Left posterior fascicular block (LPFB) was diagnosed when there 
was RAD together with RBBB. In this study, the term conduction 





•  bifasicular block;
•  primary AV block;
•  atrial fibrillation;
•  atrial flutter.
The following clinical data were captured from the patient re-
cords: sex, age, smoking status, alcohol intake; medical history—
type and duration of DM, HIV status, hypertension, compliance 
with diet and exercise as prescribed by the Society of 
Endocrinology, Metabolism and Diabetes of South Africa 
(SEMDSA) guidelines,16 performance of self-monitoring of blood 
glucose, blood pressures (both sitting and standing), height, 
weight, body mass index (BMI), waist circumference and waist-
to-height-ratio (WTHR). We recorded the glycosylated haemo-
globin (HbA1c), total cholesterol, serum triglycerides and the 
presence of proteinuria was determined using Makromed® 
(Makro Medical Pty, Denmark) urine dipsticks. A WTHR > 0.5 was 
used as a marker of obesity and a predictor of adverse cardiovas-
cular outcome.17 SEMDSA guidelines were followed outlining 
target HbA1c (≤ 7%) and triglyceride levels (< 1.7 mmol/l).16
Data handling
All data were captured onto a specially designed computerised 
database. This computer programme used the patient’s date of 
birth as the primary identifier to ensure patient confidentiality.
Statistical analysis
Continuous variables were documented as mean 
values  ±  standard deviations(SD), median and interquartile 
range. Numbers (n) and percentages (%) were expressed for 
categorical variables. Groups were compared using either chi-
square, independent samples t-test or Fisher’s exact test. 
Statistics were gathered only on patients who met the inclusion 
criteria. Analysis was done per individual variable without 
controlling for multiple comparisons. A p-value < 0.05 was used 
as indicator of significance. Data were analysed using the 
Statistical Package for Social Science (SPSS®) version 23 for 
windows (IBM Corp, Armonk, NY, USA).
Ethics approval
This retrospective data review study was approved by the 
UMgungundlovu Health Ethics Review Board (UHERB) and the 
Biomedical Research Ethics Committee (BREC)—BCA 194/15.
Results
The first ECGs of 637 patients were analysed, representing 80.1% 
of all eligible patients seen during this period. Approximately 
22% (n = 136) of these patients were HIV-infected. The majority 
(n = 95, 69.9%) of the HIV-infected patients were females. Table 1 
provides a description of the overall study patient demographics.
Over a fifth of the total patient population (n = 138, 21.7%) 
demonstrated ECG evidence of a previous MI (Table 2). The 
inferior territory was significantly more likely to be affected 
(p < 0.0001 [chi-square test]).
Comparisons between the groups with and without ECG 
evidence of MI (Table 3) revealed that patients with MI were 
statistically more likely to be female, have type 2 diabetes, not be 
compliant with lifestyle modification (diet, exercise and 
performing self-monitoring of blood glucose) and failing to 
achieve optimal weight-to-height ratio (WTHR), triglyceride and 
HbA1c levels.
Statistics for determinants of MI (type of DM, gender, patients 
achieving WTHR < 0.5, target HbA1c achieved and HIV infection) 
were not found to be significant except for ECG evidence of LVH 
(p-value 0.027 [Fisher’s exact test]) and target triglyceride 
achieved (p-value 0.016 [Fisher’s exact test]).
Evidence of LVH was present in 229 patients (36%), 198 satisfying 
voltage criteria without a strain pattern, and 31 demonstrating a 
strain pattern. Comparisons made between the groups with and 
without ECG evidence of LVH (Table 4) indicated a significant 
association between LVH and MI. There was a significant inverse 
association noted between LVH and following lifestyle 
modification (diet, exercise and performing SMBG).
Isolated T-wave inversion in the absence of LVH was noted in 59 
(9.3%) patients, and was approximately equally distributed 
across the inferior, anterior and lateral territory. Conduction 
defects were found in 113 (17.7%) and ventricular ectopics in 
43(6.8%) of the patients.
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Discussion
Studies performed in Cameroon18 and Nigeria19 found T-wave 
abnormalities to be the most common ECG aberration (20.9% 
and 22.0%) while the major ECG abnormalities detected in our 
study in decreasing order of prevalence were features suggestive 
of LVH (36.0%), MI (21.7%), conduction defects (17.7%), T-wave 
inversions (14.1%) and PVCs (6.8%). These are elaborated on 
below.
Myocardial infarctions (MIs)
The prevalence of MIs in this cohort of patients was much higher 
than in other studies conducted in Cameroon18 and Nigeria19 
(21.7% vs. 13.6% vs. 9.0%, respectively). The increased prevalence 
of MIs in South Africa (a country with one of the most competitive 
economies in sub-Saharan Africa) compared with other countries 
in Africa is possibly related to high prevalence of HIV infection, 
rapid urbanisation, increased Western diets and obesity 
associated with higher earning potential. These then translate 
into poorer glycaemic control and increased diabetes-related 
complications. The prevalence of HIV infection in South Africa is 
approximately 10%.20 Global studies have found that HIV-
infected patients are more prone to myocardial infarction due to 
either HIV itself, antiretroviral therapy (ART) or the increased life 
expectancy.21,22 A mechanism postulated for this increase of MIs 
in HIV-infected patients is that both HIV infection and ART 
increase the risk of atherosclerosis.23
Both poor glycaemic and lipid control are associated with 
increased risk of cardiovascular disease (CVD).2 Within our group 
of patients we showed that there was an association between MI 
and increased triglyceride and total cholesterol levels, WTHR, 
LVH and lifestyle modification. Anagnostis et al. showed in their 
meta-analysis that women with diabetes have a higher relative 
cardiovascular risk than men with diabetes.24 Our study 
demonstrated that female type 2 diabetes patients were more 
likely to have evidence of MI. Obesity remains a global challenge 
and is regarded as an independent risk factor for CVD.25 Obesity 
when defined using WTHR  >  0.5 was shown to be associated 
with the presence of prior MI on ECG.
Only a very small percentage (3.8%) of the patients had reported 
a history of ischaemic heart disease (IHD). From this group of IHD 
patients, only 2.2% reported having suffered an MI compared 
with 21.7% of patients who demonstrated ECG evidence of MIs. 
This significant difference in reported versus unreported MIs is 
probably related to silent MIs. Touze et al. in their prospective 
study did find that coronary heart disease does exist in a silent 
state in Black African patients.3 The increased prevalence of silent 
MIs within our population is a strong indicator of sub-optimal 
glycaemic control and the resultant long-term diabetic 
complication of autonomic neuropathy. Overall the incidence of 
silent MIs is higher in patients with diabetic autonomic 
neuropathy.26 Added to this cauldron of diabetic neuropathy is 
the high prevalence of HIV infection in South Africa. The 
combination of HIV and DM further compounds the risk of 
neuropathy.27 Studies conducted in developed countries by 
Sigurdsson et al. found that approximately one-third (30%) of 
their patients had silent MIs28 while other developed world 
studies including the UKPDS showed between 17.5% and 60% of 
all MIs were unrecognised.29–34 Our study demonstrated a much 
higher incidence of silent MIs (89.84%) compared with these 
studies performed in developed countries. A possible reason for 
this difference may be explained by the high prevalence of HIV 
infection in South Africa. In our study, we found approximately 
Table 1: Demographics of patient population




Type 1 DM 123 19.3
Type 2 DM 514 80.7
Mean (±SD) (median, 
interquartile range 
[IQR]) age in years
53.64 ± 15.01 (55.0, 20.0)
Mean (±SD) (median, 
IQR) duration of DM 
in years
8.54 ± 8.04 (6.0, 11.0)
Number of patients: 
Following diet 447 70.2
Following exercise 307 48.2
Performing self-moni-
toring of blood glucose
198 31.1
Smoking 25 3.9
Consuming alcohol 26 4.1
With hypertension 256 40.2
With HIV infection 136 21.4
Number of patients 
with BMI ≥ 25 
488 84.7
Number of patients 
with WTHR > 0.5
494 93.7
Mean (±SD) (median, 
IQR) HbA1c %
10.96 ± 2.99 (10.8, 4.6)
Mean (±SD) (median, 
IQR) BMI (kg/m2)
33.59 ± 11.86 (32.46, 9.90)




Mean (±SD) (median, 




an, IQR) triglyceride 
(mmol/l)
3.38 ± 1.65 (3.00, 1.63)
Mean (±SD) (median, 
IQR) WTHR
0.67 ± 0.11 (0.67, 0.13)




Table 2: Incidence and territory of MI
Territory of MI n Percentage





Anterior plus inferior 3 2.2%
Inferior plus lateral 1 0.7%
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must also take into consideration that using Q-waves to diagnose 
previous MI does not reflect a perfect scenario. The UKPDS31 
found a high proportion of patients who had Q-waves on ECG at 
baseline that disappeared after three years of the study. These 
Q-waves were probably false positives. However, the UKPDS also 
showed that patients with Q-waves on ECG were at significantly 
increased risk for future MI and all-cause mortality.31 Kim et al. 
also demonstrated that a significant proportion of myocardial 
infarcts never evolve into Q-waves and this was either related to 
the position of the infarct or the degree of myocardial damage.35 
22% of the total patient population to be HIV-infected. The 
combination of HIV and DM further increases the risk of 
developing neuropathy.27 Pillay et al. recently demonstrated that 
HIV-infected patients with diabetes had a higher incidence of 
neuropathy than their HIV-uninfected counterparts.27 The high 
prevalence of HIV infection coupled with suboptimal diabetes 
control within our population could possibly explain the higher 
incidence of silent MIs. Other possibilities for this high prevalence 
of silent MI in developing countries could include failing and 
aged healthcare infrastructures, and poor access to healthcare 
facilities and appropriate drugs due to financial constraints. One 
Table 3: Characteristics of patients with and without myocardial infarction
Item Patients with ECG evidence of MI 
(n = 138)
Patients with no ECG evidence of 
MI (n = 499)
p-values calculated either via chi-
square [1], independent samples 
t-test [2], Fisher’s exact test [3], 
Mann–Whitney [4]
Type 1 DM 19 (13.8%) 104 (20.8%) < 0.001 [1]
Type 2 DM 119 (86.2%) 395 (79.2%) < 0.001 [1]
Gender: Male 31 (22.5%) 137 (27.5%) < 0.001 [1]
Female 107 (77.5%) 362 (72.6%) < 0.001 [1]
Mean (±SD) (median, IQR) age (years)
Males 51.2 ± 15.2 (55.0, 30.0) 49.0 ± 15.7 (45.5, 28.0) 0.465 [2]
Females 56.7 ± 11.2 (58.5, 8.8) 54.7 ± 15.4 (56.0, 18.3) 0.226 [2]
Mean (±SD) (median, IQR) duration of 
DM (years)
9.5 ± 8.0 (6.0, 7.5) 8.3 ± 8.0 (8.0, 10.8) 0.126 [2]
Number of patients: 
Following diet 94 (21%) 353 (79%) < 0.001 [3]
Following exercise 63 (20.5%) 244 (79.5%) < 0.001 [3]
Performing self-monitoring of blood 
glucose
37 (18.7%) 161 (81.3%) < 0.001 [3]
Smoking 5 (3.6%) 20 (4.0%) 0.837 [3]
Consuming alcohol 5 (3.6%) 21 (4.2%) 0.759 [3]
With hypertension 83 (60.1%) 326 (65.3%) < 0.001 [1]
With HIV infection 29 (21%) 101 (21.4%) 0.913 [3]
Mean (±SD) (median, IQR) BMI (kg/m2)
Males 35.2 ± 9.3 (37.2, 18.2) 28.8 ± 6.8 (30.3, 7.5) 0.271 [2]
Females 35.2 ± 9.1 (34.7, 15.5) 34.5 ± 9.0 (32.6, 9.2) 0.528 [2]
Mean (±SD) (median, IQR) waist cir-
cumference (cm)
Males 102.0 ± 25.7 (105.0, 27.5) 98.6 ± 18.0 (102.0, 27.8) 0.430 [2]
Females 109.3 ± 17.5 (113.0, 76.0) 107.4 ± 16.6 (104.8, 22.3) 0.342 [2]
Mean (±SD) (median, IQR) WTHR
Males 0.70 ± 0.14 (0.64, 0.26) 0.61 ± 0.08 (0.60, 0.14) 0.119 [4]
Females 0.70 ± 0.12 (0.71, 0.16) 0.68 ± 0.12 (0.68, 0.09) 0.413 [4]
Patients achieving WTHR < 0.5 6 (4.4%) 32 (6.4%) < 0.001 [1]
Mean sitting blood pressure (mmHg)
Systolic BP 136 132
Diastolic BP 81 77
Mean (±SD) (median, IQR) HbA1c% 11.4 ± 3.2 (11.3, 3.5) 10.8 ± 2.9 (11.2, 4.9) 0.045 [2]
Mean (±SD) (median, IQR) total choles-
terol (mmol/l)
6.0 ± 1.4 (5.2, 1.3) 5.6 ± 0.9 (5.5, 1.2) 0.027 [2]
Mean (±SD) (median, IQR) triglyceride 
level (mmol/l)
2.9 ± 1.3 (2.9, 1.9) 3.1 ± 1.4 (3.0, 1.7) 0.462 [2]
Number of patients achieving target:
HbA1c% 16 (11.6%) 117 (23.5%) 0.018 [3]
Triglyceride 76 (55.1%) 332 (66.6%) 0.016 [3]
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Olamoyegun et al. in Nigeria19 and Lutale et al. in Tanzania39 (36% 
vs. 16.4% vs. 18.5% vs. 16%, respectively). Muddu et al. also 
showed that the prevalence in Uganda of echocardiographic-
diagnosed LVH in newly diagnosed patients with diabetes is 
19.3%.40 A recent study carried out by Lohrmann et al. in disease-
free black South Africans found a prevalence of LVH diagnosed 
by ECG voltage criteria to be 13.1%.41
LVH is strongly associated with hypertension and diabetes and 
carries an increased risk for cardiovascular mortality,42,43 CHD and 
cerebrovascular disease. Obesity and glucose intolerance may 
account for other causes of LVH.44 South Africa has the highest 
incidence of obesity in females in sub-Saharan Africa.45 Our study 
demonstrated that there was a significant correlation between 
BMI and LVH. The increased incidence of poor glycaemic 
control5,16 and high levels of obesity in South Africa could 
possibly explain the higher prevalence of LVH and LVH without 
The best approach to detecting silent MI would probably be to 
do serial ECGs.
Between 40% and 50% of all MIs worldwide are inferior infarctions 
and they are generally regarded as carrying a better prognosis 
than anterior MIs.36 Inferior territory MI was the most common 
territory involved in our cohort of patients when compared with 
anterior, lateral and antero-lateral territories. This may possibly 
be reflecting that patients with infarcts in other territories may 
actually not be surviving long enough to present to healthcare 
facilities after suffering an MI at home.
LVH
LVH was the most common ECG finding (36%) in our cohort of 
patients. This result is similar to the prevalence of LVH found in 
Gambia by Jobe et al. and in Nepal by Prakash et al. (36% vs. 
35.2% vs. 34%, respectively)37,38 and is approximately double that 
found in the studies done by Dzudie et al. in Cameroon,18 
Table 4: Characteristics of patients with and without ECG evidence of LVH
Item Patients with ECG evidence of 
LVH (n = 229)
Patients with no ECG evidence of 
LVH (n = 408)
Tests used for p-values, chi-
square [1], independent samples 
t-test [2], Fisher’s exact [3], 
Mann–Whitney [4]
Males 71 (31.0%) 97 (23.8%) 0.045 [1]
Females 158 (69.0%) 311 (76.2%) < 0.001 [1]
Type 1 DM 37 (16.2%) 86 (21.1%) < 0.001 [1]
Type 2 DM 192 (83.8%) 322 (78.9%) < 0.001 [1]
Mean (±SD) (median, IQR) age (years) 53.9 ± 15.7 (54.0, 17.0) 53.5 ± 14.7 (55.0, 18.5) 0.725 [2]
Mean (±SD) (median, IQR) duration of 
DM (years)
8.2 ± 7.9 (4.0, 8.0) 8.7 ± 8.1 (8.5, 9.5) 0.403 [2]
Number of patients: 
Following diet 158 (35.3%) 289 (64.7%) < 0.001 [3]
Following exercise 113 (36.8%) 194 (63.2%) < 0.001 [3]
Performing self-monitoring of blood 
glucose
70 (35.4%) 128 (64.6%) < 0.001 [3]
9 (3.9%) 16 (3.9%) 1.000 [3]
Smoking 9 (3.9%) 17 (4.2%) 1.000 [3]
Consuming alcohol with HIV infection 52 (22.7%) 84 (20.6%) 0.006 [1]
Mean (±SD) (median, IQR) HbA1c % 10.8 ± 3.0 (11.1, 3.8) 11.1 ± 3.0 (11.3, 4.8) 0.201 [2]
Mean (±SD) (median, IQR) total choles-
terol (mmol/l)
5.7 ± 1.0 (5.7, 1.1) 5.6 ± 1.0 (5.4, 1.2) 0.583 [2]
Mean (±SD) (median, IQR) triglyceride 
(mmol/l)
3.0 ± 1.5 (2.9, 1.7) 3.0 ± 1.3 (3.1, 1.7) 0.691 [2]
Mean sitting BP (mmHg) 139/80 129/77
Total number of MIs 65 (28.4%) 79 (19.4%) 0.027 [3]
Mean (±SD) (median, IQR) BMI
Males 28.5 ± 6.33 (27.6, 8.9) 29.8 ± 7.5 (29.7, 8.9) 0.238 [4]
Females 33.68 ± 7.8 (33.1, 8.9) 35.2 ± 9.5 (34.7, 10.4) 0.159 [4]
Mean (±SD) (median, IQR) Waist cir-
cumference (cm)
Males 95.6 ± 18.3 (96.0, 22.0) 101.2 ± 19.2 (102.0, 23.0) 0.185 [4]
Females 106.5 ± 16.2 (108.0, 19.8) 108.2 ± 17.2 (108.0, 23.0) 0.646 [4]
Mean (±SD) (median, IQR) WTHR
Males 0.58 ± 0.11 (0.58, 0.12) 0.60 ± 0.11 (0.59, 0.13) 0.225 [4]
Females 0.68 ± 0.11 (0.69, 0.11) 0.70 ± 0.11 (0.69, 0.14) 0.511 [4]
Number of patients achieving WTHR 
< 0.5
14 (7.5%) 19 (5.6%) 0.452 [3]
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by ECG voltage criteria to be 13.1%.41
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carries an increased risk for cardiovascular mortality,42,43 CHD and 
cerebrovascular disease. Obesity and glucose intolerance may 
account for other causes of LVH.44 South Africa has the highest 
incidence of obesity in females in sub-Saharan Africa.45 Our study 
demonstrated that there was a significant correlation between 
BMI and LVH. The increased incidence of poor glycaemic 
control5,16 and high levels of obesity in South Africa could 
possibly explain the higher prevalence of LVH and LVH without 
The best approach to detecting silent MI would probably be to 
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Between 40% and 50% of all MIs worldwide are inferior infarctions 
and they are generally regarded as carrying a better prognosis 
than anterior MIs.36 Inferior territory MI was the most common 
territory involved in our cohort of patients when compared with 
anterior, lateral and antero-lateral territories. This may possibly 
be reflecting that patients with infarcts in other territories may 
actually not be surviving long enough to present to healthcare 
facilities after suffering an MI at home.
LVH
LVH was the most common ECG finding (36%) in our cohort of 
patients. This result is similar to the prevalence of LVH found in 
Gambia by Jobe et al. and in Nepal by Prakash et al. (36% vs. 
35.2% vs. 34%, respectively)37,38 and is approximately double that 
found in the studies done by Dzudie et al. in Cameroon,18 
Table 4: Characteristics of patients with and without ECG evidence of LVH
Item Patients with ECG evidence of 
LVH (n = 229)
Patients with no ECG evidence of 
LVH (n = 408)
Tests used for p-values, chi-
square [1], independent samples 
t-test [2], Fisher’s exact [3], 
Mann–Whitney [4]
Males 71 (31.0%) 97 (23.8%) 0.045 [1]
Females 158 (69.0%) 311 (76.2%) < 0.001 [1]
Type 1 DM 37 (16.2%) 86 (21.1%) < 0.001 [1]
Type 2 DM 192 (83.8%) 322 (78.9%) < 0.001 [1]
Mean (±SD) (median, IQR) age (years) 53.9 ± 15.7 (54.0, 17.0) 53.5 ± 14.7 (55.0, 18.5) 0.725 [2]
Mean (±SD) (median, IQR) duration of 
DM (years)
8.2 ± 7.9 (4.0, 8.0) 8.7 ± 8.1 (8.5, 9.5) 0.403 [2]
Number of patients: 
Following diet 158 (35.3%) 289 (64.7%) < 0.001 [3]
Following exercise 113 (36.8%) 194 (63.2%) < 0.001 [3]
Performing self-monitoring of blood 
glucose
70 (35.4%) 128 (64.6%) < 0.001 [3]
9 (3.9%) 16 (3.9%) 1.000 [3]
Smoking 9 (3.9%) 17 (4.2%) 1.000 [3]
Consuming alcohol with HIV infection 52 (22.7%) 84 (20.6%) 0.006 [1]
Mean (±SD) (median, IQR) HbA1c % 10.8 ± 3.0 (11.1, 3.8) 11.1 ± 3.0 (11.3, 4.8) 0.201 [2]
Mean (±SD) (median, IQR) total choles-
terol (mmol/l)
5.7 ± 1.0 (5.7, 1.1) 5.6 ± 1.0 (5.4, 1.2) 0.583 [2]
Mean (±SD) (median, IQR) triglyceride 
(mmol/l)
3.0 ± 1.5 (2.9, 1.7) 3.0 ± 1.3 (3.1, 1.7) 0.691 [2]
Mean sitting BP (mmHg) 139/80 129/77
Total number of MIs 65 (28.4%) 79 (19.4%) 0.027 [3]
Mean (±SD) (median, IQR) BMI
Males 28.5 ± 6.33 (27.6, 8.9) 29.8 ± 7.5 (29.7, 8.9) 0.238 [4]
Females 33.68 ± 7.8 (33.1, 8.9) 35.2 ± 9.5 (34.7, 10.4) 0.159 [4]
Mean (±SD) (median, IQR) Waist cir-
cumference (cm)
Males 95.6 ± 18.3 (96.0, 22.0) 101.2 ± 19.2 (102.0, 23.0) 0.185 [4]
Females 106.5 ± 16.2 (108.0, 19.8) 108.2 ± 17.2 (108.0, 23.0) 0.646 [4]
Mean (±SD) (median, IQR) WTHR
Males 0.58 ± 0.11 (0.58, 0.12) 0.60 ± 0.11 (0.59, 0.13) 0.225 [4]
Females 0.68 ± 0.11 (0.69, 0.11) 0.70 ± 0.11 (0.69, 0.14) 0.511 [4]
Number of patients achieving WTHR 
< 0.5
14 (7.5%) 19 (5.6%) 0.452 [3]
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control and body weight will help in improving long-term 
complications like MIs.
Strengths and limitations of this study
•  Provides an in-depth understanding of ECG abnormalities 
found in this cohort of black South African patients with 
diabetes.
•  Since there are limited data on such a study in South Africa 
this study provides an excellent opportunity to compare 
these findings with findings from other countries in Africa.
•  This study helps us understand the high prevalence of silent 
myocardial infarctions in this cohort of patients.
•  The study only analysed  80.1% of eligible patients. Although 
all patients were advised to have their ECG performed annu-
ally not all patients followed this advice.
•  The ECGs were interpreted by only one observer and there-
fore only one description or version of the ECG interpreta-
tion is provided.j1
•  The use of Q-waves to diagnose previous myocardial infarc-
tion is not a perfect scenario as there is a possibility of both 
false positives and negative findings. However, this study 
was done in a resource-limited developing country where 
more invasive investigations are both costly and often una-
vailable to these patients. Performing an ECG provides a rel-
atively easy, non-invasive and cheap method that can be 
done in these settings.
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